Shreya Bhandari, Hasmitha Kamineni. Utilization of Intravenous (IV) Curcumin, Genistein, and Trastuzumab to Reduce HER2 receptors in Breast Cancer Patients. Int. j. res. appl. sci. biotechnol. [Internet]. 2021 Jul. 31 [cited 2024 Jul. 16];8(4):104-9. Available from: https://ijrasb.com/index.php/ijrasb/article/view/204